[go: up one dir, main page]

TN2013000045A1 - Anti-n3pglu amyloid beta peptide antibodies and uses thereof - Google Patents

Anti-n3pglu amyloid beta peptide antibodies and uses thereof

Info

Publication number
TN2013000045A1
TN2013000045A1 TNP2013000045A TN2013000045A TN2013000045A1 TN 2013000045 A1 TN2013000045 A1 TN 2013000045A1 TN P2013000045 A TNP2013000045 A TN P2013000045A TN 2013000045 A TN2013000045 A TN 2013000045A TN 2013000045 A1 TN2013000045 A1 TN 2013000045A1
Authority
TN
Tunisia
Prior art keywords
amyloid beta
beta peptide
peptide antibodies
n3pglu
n3pglu amyloid
Prior art date
Application number
TNP2013000045A
Other languages
English (en)
Inventor
Jirong Lu
Ying Tang
Ronald Bradley Demattos
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2011/046994 external-priority patent/WO2012021469A1/fr
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of TN2013000045A1 publication Critical patent/TN2013000045A1/fr

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
TNP2013000045A 2011-08-09 2013-02-01 Anti-n3pglu amyloid beta peptide antibodies and uses thereof TN2013000045A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2011/046994 WO2012021469A1 (fr) 2010-08-12 2011-08-09 Anticorps anti-peptide bêta-amyloïde n3pglu et leurs utilisations

Publications (1)

Publication Number Publication Date
TN2013000045A1 true TN2013000045A1 (en) 2014-06-25

Family

ID=54360753

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000045A TN2013000045A1 (en) 2011-08-09 2013-02-01 Anti-n3pglu amyloid beta peptide antibodies and uses thereof

Country Status (1)

Country Link
TN (1) TN2013000045A1 (fr)

Similar Documents

Publication Publication Date Title
PH12013500277A1 (en) ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
EP2579894A4 (fr) Anticorps anti-cgrp
WO2014124334A3 (fr) Anticorps anti-transthyrétine et leurs utilisations
PH12014501164A1 (en) Anti-cd98 antibodies and methods of use thereof
NZ630542A (en) Methods of treating a tauopathy
NZ727020A (en) Antibodies and antigen-binding fragments that specifically bind to microtubule-associated protein tau
MX2018005720A (es) Anticuerpos pd-l1, fragmento de union al antigeno del mismo, y aplicacion medica de ello.
SG194701A1 (en) Anti-cd40 antibodies and methods of use
EP3702372A3 (fr) Anticorps humains anti-cd40
NZ707086A (en) Anti-cd40 antibodies and methods of use
SG10201902924RA (en) Antibodies that bind ebola glycoprotein and uses thereof
MX2016002826A (es) Anticuerpos anti-b7-h1 para tratar tumores.
MX342240B (es) Anticuerpos anti-fgfr4 y metodos de uso.
IN2014DN05885A (fr)
EP2614085A4 (fr) Anticorps anti-il-1 bêta et leurs procédés d'utilisation
WO2012173846A3 (fr) Macrocycles peptidomimétiques
PH12014500841B1 (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
WO2012166626A8 (fr) Réactifs et procédés pour traiter une maladie dentaire
NZ626242A (en) Anti-asic1 antibodies and uses thereof
MX2015008534A (es) COMPOSICIONES DE ANTICUERPO ANTI-INTEGRINA ß1 Y METODOS DE USO DE LAS MISMAS.
MX2015002465A (es) Anticuerpos monoclonales para mejorar o inhibir factor de crecimiento 1 similar a insulina (igf-1).
HK1198135A1 (en) Prevention and treatment of pain using antibodies to lysophosphatidic acid
PH12015501650A1 (en) Human antibody specific to human metapneumovirus, or antigen-binding fragment thereof
PH12013500432A1 (en) Anti-vegfr-3 antibody compositions
MX2013011629A (es) Uso de un agente que consiste en anticuerpos y/o antagonistas de factor de crecimiento tipo insulina.